As of 2024-12-11, the Relative Valuation of Halozyme Therapeutics Inc (HALO) is 108.35 USD. This relative valuation is based on P/E multiples. With the latest stock price at 49.06 USD, the upside of Halozyme Therapeutics Inc based on Relative Valuation is 120.8%.
The range of the Relative Valuation is 56.48 - 152.69 USD.
| Range | Selected | |
| Trailing P/E multiples | 35.0x - 49.5x | 42.2x |
| Forward P/E multiples | 20.6x - 42.4x | 31.5x |
| Fair Price | 56.48 - 152.69 | 108.35 |
| Upside | 15.1% - 211.2% | 120.8% |
| Date | P/E |
| 2024-12-10 | 15.90 |
| 2024-12-09 | 15.90 |
| 2024-12-06 | 15.69 |
| 2024-12-05 | 15.58 |
| 2024-12-04 | 15.76 |
| 2024-12-03 | 15.72 |
| 2024-12-02 | 15.75 |
| 2024-11-29 | 15.63 |
| 2024-11-27 | 15.71 |
| 2024-11-26 | 15.49 |
| 2024-11-25 | 15.49 |
| 2024-11-22 | 15.88 |
| 2024-11-21 | 14.82 |
| 2024-11-20 | 14.83 |
| 2024-11-19 | 14.53 |
| 2024-11-18 | 13.80 |
| 2024-11-15 | 14.80 |
| 2024-11-14 | 17.49 |
| 2024-11-13 | 19.00 |
| 2024-11-12 | 19.32 |
| 2024-11-11 | 19.80 |
| 2024-11-08 | 19.77 |
| 2024-11-07 | 19.34 |
| 2024-11-06 | 19.66 |
| 2024-11-05 | 19.04 |
| 2024-11-04 | 18.95 |
| 2024-11-01 | 18.53 |
| 2024-10-31 | 16.39 |
| 2024-10-30 | 16.40 |
| 2024-10-29 | 16.42 |
| 2024-10-28 | 16.36 |
| 2024-10-25 | 15.97 |
| 2024-10-24 | 15.98 |
| 2024-10-23 | 16.47 |
| 2024-10-22 | 16.71 |
| 2024-10-21 | 16.78 |
| 2024-10-18 | 17.06 |
| 2024-10-17 | 16.95 |
| 2024-10-16 | 17.33 |
| 2024-10-15 | 17.45 |
| 2024-10-14 | 17.49 |
| 2024-10-11 | 17.18 |
| 2024-10-10 | 16.90 |
| 2024-10-09 | 16.42 |
| 2024-10-08 | 17.55 |
| 2024-10-07 | 17.46 |
| 2024-10-04 | 19.18 |
| 2024-10-03 | 19.59 |
| 2024-10-02 | 18.85 |
| 2024-10-01 | 18.36 |